Eda Cengiz
Overview
Explore the profile of Eda Cengiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seetharaman S, Cengiz E
J Diabetes Sci Technol
. 2025 Mar;
19(2):311-320.
PMID: 40022528
Type 1 diabetes (T1D) necessitates lifelong insulin therapy due to the autoimmune destruction of insulin-producing pancreatic beta cells. Despite advancements in diabetes technology and insulin formulations, maintaining optimal glycemic outcomes...
2.
Cengiz E, Danne T, Ahmad T, Ayyavoo A, Beran D, Codner E, et al.
Horm Res Paediatr
. 2025 Jan;
97(6):584-614.
PMID: 39884261
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults...
3.
Seetharaman S, Cengiz E
J Diabetes Sci Technol
. 2024 Dec;
19(2):304-310.
PMID: 39707844
Background: Type 1 diabetes (T1D) is characterized by the autoimmune destruction of pancreatic beta cells, leading to lifelong insulin dependence. Despite advancements in insulin therapies and glucose monitoring, maintaining optimal...
4.
Shah V, Peters A, Umpierrez G, Sherr J, Akturk H, Aleppo G, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):191-216.
PMID: 39517127
With increasing prevalence of obesity and cardiovascular diseases, there is a growing interest in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as an adjunct therapy in type 1 diabetes...
5.
Klonoff D, Freckmann G, Pleus S, Kovatchev B, Kerr D, Tse C, et al.
J Diabetes Sci Technol
. 2024 Oct;
18(6):1346-1361.
PMID: 39369312
Introduction: An error grid compares measured versus reference glucose concentrations to assign clinical risk values to observed errors. Widely used error grids for blood glucose monitors (BGMs) have limited value...
6.
Klonoff D, Ayers A, Ho C, Fabris C, Villa-Tamayo M, Allen E, et al.
J Diabetes Sci Technol
. 2024 Sep;
18(6):1472-1479.
PMID: 39240028
Introduction: Insulin pump therapy can be adversely affected by interruption of insulin flow, leading to a rise in blood glucose (BG) and subsequently of blood beta-hydroxybutyrate (BHB) ketone levels. Methods:...
7.
Tian T, Aaron R, DuNova A, Jendle J, Kerr D, Cengiz E, et al.
J Diabetes Sci Technol
. 2024 Mar;
18(5):1208-1244.
PMID: 38528741
Diabetes Technology Society hosted its annual Diabetes Technology Meeting from November 1 to November 4, 2023. Meeting topics included digital health; metrics of glycemia; the integration of glucose and insulin...
8.
Huang J, Yeung A, Bergenstal R, Castorino K, Cengiz E, Dhatariya K, et al.
J Diabetes Sci Technol
. 2023 Feb;
18(3):714-726.
PMID: 36794812
Ketone bodies are an energy substrate produced by the liver and used during states of low carbohydrate availability, such as fasting or prolonged exercise. High ketone concentrations can be present...
9.
Schiavon M, Galderisi A, Basu A, Kudva Y, Cengiz E, Dalla Man C
Diabetes Technol Ther
. 2023 Jan;
25(4):270-278.
PMID: 36648253
Estimation of insulin sensitivity (S) and its daily variation are key for optimizing insulin therapy in patients with type 1 diabetes (T1D). We recently developed a method for S estimation...
10.
Cengiz E, Danne T, Ahmad T, Ayyavoo A, Beran D, Ehtisham S, et al.
Pediatr Diabetes
. 2022 Dec;
23(8):1277-1296.
PMID: 36537533
No abstract available.